
FDA reverses decision to halt compounding of Terzepetide, for now
Update: 2024-10-28
Share
Description
Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.
Comments
In Channel